COMMUNIQUÉS West-GlobeNewswire

Successful Commercial Launch of Ryoncil®
18/07/2025
Activity Report for Quarter Ended June 30, 2025 (Appendix 4C) NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory [...]
SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
18/07/2025
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences [...]
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
17/07/2025
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that updated clinical data from its ongoing open-label Phase 1b study evaluating tegoprubart for [...]
NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan
17/07/2025
In connection with HekaBio’s recently announced strategic investment in NKGen, the partnership will expedite the regulatory, manufacturing, and commercial development of NKGen’s autologous NK cell therapy, troculeucel, [...]
Exagen Inc. Appoints Chas McKhann to Board of Directors
17/07/2025
CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its Board of Directors, [...]
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2025
CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on July 11, [...]
LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025
17/07/2025
SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its second quarter 2025 earnings [...]
Hapbee Announces Insider Purchase of $1 Million USD via Closing of Non-Brokered Private Placement
17/07/2025
Follows Prior Investment by Jaylen Brown and the New Leadership Team Underscoring Growing Confidence in Hapbee VANCOUVER, British Columbia, July 17, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCID [...]
Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
17/07/2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, [...]
Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset
17/07/2025
Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”) , today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, [...]
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
17/07/2025
AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the [...]
Advancing Preventive Vascular Inflammation in the South with SmartVascular Dx™ Test
17/07/2025
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce the [...]
FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT
17/07/2025
WEST PALM BEACH, FLORIDA, July 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “ Company ”), today announced that its Board of Directors has approved a 1 for 1.99 reverse stock [...]
Ontario Health Coalition and Health Coalitions from across Canada issued a joint statement in advance of the gathering of First Ministers and the Council of the Federation:
18/07/2025
Any governments across Canada that claim to prioritize the economy while dismantling our public health care have lost their moral compass TORONTO, July 17, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition and [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels NANTES, France, 17 juillet 2025, 18h30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , société de biotechnologie qui [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics Launches Newsletter for Individual Shareholders NANTES, France, July 17, 2025, 6:30pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , a biotech company dedicated to developing [...]
Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management
17/07/2025
More than 50% of patients saw treatment changes following Heartflow Plaque Analysis – driving promising LDL cholesterol improvements and individualized care MONTREAL, July 17, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. , [...]
Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
17/07/2025
HUNTSVILLE, Ontario, July 17, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a shadow summit, rally, [...]
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
17/07/2025
PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”) , a clinical-stage biotechnology company specializing in regenerative medicine, [...]

Pages